Regulatory Insights

  1. We Made Five Predictions For Clinical Research Last Year. Here's What Happened 1/22/2026

    Review 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.

  2. What the FDA Looks For In Global Development Programs Today 1/16/2026

    Mastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.

  3. The Clinical Trial Rescue Triage Playbook 1/15/2026

    Quickly assess clinical trial risks by evaluating site impact, patient safety, and budget tradeoffs. Turn high-pressure rescue scenarios into clear, actionable paths for your research team.

  4. No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure 1/14/2026

    This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.

  5. Designing The Path: Strategic Planning To Maximize Biotech Appeal 1/14/2026

    Aligning clinical, regulatory, and operational strategies boosts biotech investment appeal. Strategic planning, clear milestones, and risk mitigation accelerate development and attract funding.

  6. Crafting The Vision: Building A Strong Value Story For Biotechs 1/14/2026

    Early-stage biotechs need more than science — they need a clear vision. Learn to craft a value story that shows differentiation, market potential, and patient impact to attract investors and partners.

  7. FDA Pushes For Patient Voice: ePRO In Oncology Trials 1/8/2026

    FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.

  8. 6 Key Implications Of EU Clinical Trials Regulation 1/7/2026

    Centralized submissions, greater transparency, and stronger patient protections reshape EU clinical trials, impacting timelines, costs, and strategies for sponsors and CROs.

  9. A New, AI-Augmented Horizon For Safety And Pharmacovigilance 1/6/2026

    Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.

  10. Psychiatric Drug Development Renaissance: With Familiar Risks 1/6/2026

    Emerging psychiatric therapies bring hope, but progress is fragile. Biomarker-driven, mechanism-first approaches help overcome biological, regulatory, and commercial barriers.